Gestational Outcomes of Pregnant Women Who Have Had Invasive Prenatal Testing for the Prenatal Diagnosis of Duchenne Muscular Dystrophy

Table 3

Percentages, demographic features, prenatal diagnostic tests, and obstetric outcomes of the pregnancies in healthy and carrier female fetus groups, represented as median and minimum-maximum values.

DMD status	Healthy; (n=28)	Carrier; (n=15)	P value
Percentage	65.2%	34.8%
CVS	24 (85.8%)	9 (60%)
Amniocentesis	4 (14.2%)	6 (40%)
Age (years) of; mother	30 (20 to 43)	31 (19 to 41)	1.0
Gravida	3 (1 to 7)	3 (1 to 7)	0.574
Parity	1 (0 to 3)	1 (0 to 4)	0.285
Gestational week at; birth	39 (37 to 40)	38 (37 to 41)	0.596
Birthweight (grams)	3250 (2600 to 3800)	2900 (2500 to 3100)	0.596
5^th minute APGAR	10 (7 to 10)	8 (7 to 10)	0.825
CS rate	14/28 (50%)	11/15 (73.3%)

CVS: Chorion villus sampling, AC: Amniocentesis, CS: Cesarean.